Market Overview:
The global tuberculosis diagnostic market is expected to grow at a CAGR of 6.5% from 2018 to 2030. The growth in the market can be attributed to factors such as rising incidence of tuberculosis, increasing awareness about tuberculosis diagnosis and treatment, and technological advancements in the field of tuberculosis diagnosis. The global tuberculosis diagnostic market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into radiographic method, diagnostic laboratory methods, nucleic acid testing (NAT), phage assay detection latent infection (PADLI), cytokine detection assay (CDA), and drug resistance detection. The radiographic method dominates the global TB diagnostics market owing to its high accuracy rate and easy availability across hospitals and clinics worldwide. However, NAT is expected to grow at a higher CAGR during the forecast period due to its advantages over other methods such as high sensitivity and specificity for detecting Mycobacterium Tuberculosis complex strains including both drug-sensitive strains as well as multidrug-resistant strains).
Product Definition:
TB diagnostic is a medical test used to determine if a person has tuberculosis (TB). The test can also help identify which type of TB the person has. TB diagnostic is important because it can help doctors prescribe the correct treatment for the person.
Radiographic Method:
Radiographic method is a diagnostic procedure that uses x-ray, ultrasound or other radiations for medical diagnosis. It is the primary tool used by doctors to identify and treat diseases. The global increase in the prevalence of tuberculosis (TB) has led to an upsurge in demand for its diagnosis which has further propelled growth of this market globally.
Diagnostic Laboratory Methods:
The global diagnostic laboratory methods and its usage in TB diagnostics market is analyzed by considering various factors including the prevalence rate of tuberculosis, drug resistance, patient awareness levels and healthcare expenditure. The study encompasses a period from 2014 to 2025 with forecast up to 2030.
Application Insights:
The others application segment dominated the market in 2017 and is expected to witness significant growth over the forecast period. This can be attributed to an increase in demand for rapid testing methods that are highly sensitive and specific for tuberculosis infection, which has resulted in the adoption of laboratory tests other than sputum microscopy.
Radiographic imaging was observed to account for a major share owing to its ability to detect active TB as well as latent pulmonary TB disease with high sensitivity and specificity. However, increasing use of molecular biology techniques such as real-time polymerase chain reaction (PCR) has led clinicians towards adopting faster testing methods such as nucleic acid testing or mycobacterium culture while diagnosing TB infections.
Regional Analysis:
North America dominated the global market in 2017. The presence of well-developed healthcare infrastructure and high adoption rate for advanced diagnostic techniques are some factors responsible for its large share. Moreover, increasing incidence of infectious diseases is also one of the major factors contributing to its large share as it facilitates early diagnosis thus facilitating treatment and preventing complications.
Asia Pacific is expected to grow at a lucrative CAGR over the forecast period owing to rising prevalence of infectious diseases coupled with growing target population base in this region.
Growth Factors:
- Increasing incidence of tuberculosis (TB) across the globe.
- Rising awareness about TB and its diagnosis among people.
- Growing demand for rapid, accurate, and affordable TB diagnostic tests.
- Technological advancements in TB diagnostics industry.
Scope Of The Report
Report Attributes
Report Details
Report Title
TB Diagnostic Market Research Report
By Type
Radiographic Method, Diagnostic Laboratory Methods, Nucleic Acid Testing, Phage Assay, Detection of Latent Infection, Cytokine Detection Assay, Detection of Drug Resistance, Others
By Application
Hospitals, Clinics, Others
By Companies
Abbott Laboratories, Abbott, Becton Dickinson and Company, bioMrieux, Cepheid, F. Hoffman La Roche, Hain Lifescience, Hologic Corporation, Thermo Fisher Scientific, Qiagen
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
145
Number of Tables & Figures
102
Customization Available
Yes, the report can be customized as per your need.
Global TB Diagnostic Market Report Segments:
The global TB Diagnostic market is segmented on the basis of:
Types
Radiographic Method, Diagnostic Laboratory Methods, Nucleic Acid Testing, Phage Assay, Detection of Latent Infection, Cytokine Detection Assay, Detection of Drug Resistance, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Laboratories
- Abbott
- Becton Dickinson and Company
- bioMrieux
- Cepheid
- F. Hoffman La Roche
- Hain Lifescience
- Hologic Corporation
- Thermo Fisher Scientific
- Qiagen
Highlights of The TB Diagnostic Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Radiographic Method
- Diagnostic Laboratory Methods
- Nucleic Acid Testing
- Phage Assay
- Detection of Latent Infection
- Cytokine Detection Assay
- Detection of Drug Resistance
- Others
- By Application:
- Hospitals
- Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the TB Diagnostic Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
TB diagnostic is the process of confirming that a person has TB disease. This can be done through a number of methods, including chest x-ray, sputum analysis, and blood tests.
Some of the major companies in the tb diagnostic market are Abbott Laboratories, Abbott, Becton Dickinson and Company, bioMrieux, Cepheid, F. Hoffman La Roche, Hain Lifescience, Hologic Corporation, Thermo Fisher Scientific, Qiagen.
The tb diagnostic market is expected to register a CAGR of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 TB Diagnostic Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 TB Diagnostic Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 TB Diagnostic Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the TB Diagnostic Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global TB Diagnostic Market Size & Forecast, 2018-2028
4.5.1 TB Diagnostic Market Size and Y-o-Y Growth
4.5.2 TB Diagnostic Market Absolute $ Opportunity
Chapter 5 Global TB Diagnostic Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 TB Diagnostic Market Size Forecast by Type
5.2.1 Radiographic Method
5.2.2 Diagnostic Laboratory Methods
5.2.3 Nucleic Acid Testing
5.2.4 Phage Assay
5.2.5 Detection of Latent Infection
5.2.6 Cytokine Detection Assay
5.2.7 Detection of Drug Resistance
5.2.8 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global TB Diagnostic Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 TB Diagnostic Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global TB Diagnostic Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 TB Diagnostic Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America TB Diagnostic Analysis and Forecast
9.1 Introduction
9.2 North America TB Diagnostic Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America TB Diagnostic Market Size Forecast by Type
9.6.1 Radiographic Method
9.6.2 Diagnostic Laboratory Methods
9.6.3 Nucleic Acid Testing
9.6.4 Phage Assay
9.6.5 Detection of Latent Infection
9.6.6 Cytokine Detection Assay
9.6.7 Detection of Drug Resistance
9.6.8 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America TB Diagnostic Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe TB Diagnostic Analysis and Forecast
10.1 Introduction
10.2 Europe TB Diagnostic Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe TB Diagnostic Market Size Forecast by Type
10.6.1 Radiographic Method
10.6.2 Diagnostic Laboratory Methods
10.6.3 Nucleic Acid Testing
10.6.4 Phage Assay
10.6.5 Detection of Latent Infection
10.6.6 Cytokine Detection Assay
10.6.7 Detection of Drug Resistance
10.6.8 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe TB Diagnostic Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific TB Diagnostic Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific TB Diagnostic Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific TB Diagnostic Market Size Forecast by Type
11.6.1 Radiographic Method
11.6.2 Diagnostic Laboratory Methods
11.6.3 Nucleic Acid Testing
11.6.4 Phage Assay
11.6.5 Detection of Latent Infection
11.6.6 Cytokine Detection Assay
11.6.7 Detection of Drug Resistance
11.6.8 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific TB Diagnostic Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America TB Diagnostic Analysis and Forecast
12.1 Introduction
12.2 Latin America TB Diagnostic Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America TB Diagnostic Market Size Forecast by Type
12.6.1 Radiographic Method
12.6.2 Diagnostic Laboratory Methods
12.6.3 Nucleic Acid Testing
12.6.4 Phage Assay
12.6.5 Detection of Latent Infection
12.6.6 Cytokine Detection Assay
12.6.7 Detection of Drug Resistance
12.6.8 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America TB Diagnostic Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) TB Diagnostic Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) TB Diagnostic Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) TB Diagnostic Market Size Forecast by Type
13.6.1 Radiographic Method
13.6.2 Diagnostic Laboratory Methods
13.6.3 Nucleic Acid Testing
13.6.4 Phage Assay
13.6.5 Detection of Latent Infection
13.6.6 Cytokine Detection Assay
13.6.7 Detection of Drug Resistance
13.6.8 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) TB Diagnostic Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 TB Diagnostic Market: Competitive Dashboard
14.2 Global TB Diagnostic Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott Laboratories
14.3.2 Abbott
14.3.3 Becton Dickinson and Company
14.3.4 bioMrieux
14.3.5 Cepheid
14.3.6 F. Hoffman La Roche
14.3.7 Hain Lifescience
14.3.8 Hologic Corporation
14.3.9 Thermo Fisher Scientific
14.3.10 Qiagen
